Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Genetic Tech (AGTC)

Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Applied Genetic Tech 14193 NW 119TH TERRACE SUITE 10 ALACHUA FL 32615 USA

www.agtc.com P: 386-462-2204

Description:

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida.

Key Statistics

Overview:

Market Capitalization, $K 26,620
Enterprise Value, $K -1,330
Shares Outstanding, K 67,632
Annual Sales, $ 330 K
Annual Net Income, $ -68,940 K
Last Quarter Sales, $ 330 K
Last Quarter Net Income, $ -18,390 K
60-Month Beta 1.59
% of Insider Shareholders 4.10%
% of Institutional Shareholders 22.05%
Float, K 64,859
% Float 95.90%
Short Volume Ratio 0.76

Growth:

1-Year Return -83.46%
3-Year Return -86.29%
5-Year Return -89.71%
5-Year Revenue Growth -99.16%
5-Year Earnings Growth -100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.33 on 05/16/22
Next Earnings Date 12/06/22
Earnings Per Share ttm -1.18
EPS Growth vs. Prev Qtr 26.67%
EPS Growth vs. Prev Year 17.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AGTC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -192.90%
Return-on-Assets % -92.54%
Profit Margin % -20,890.91%
Debt/Equity 0.39
Price/Sales 80.91
Price/Cash Flow N/A
Price/Book 1.51
Book Value/Share 0.58
Interest Coverage -24.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar